Relative to the base-case scenario where immediate sampling is performed on both newly infected and recovered individuals, the following results are observed. Eliminating recovered sampling increases average costs by 5%, a one-period delay between transitions and control action increases costs 6%, a two-period delay increases costs 14% and eliminating all sampling increases costs by 34%.